aod9604 - efficacy and marketing, page-45

Dear all,

Much discussion today on AOD as a fat burner. To repeat the anti-obesity study will cost another $50million or so, which is possible, but the patent life for anti-obesity will be so short the money would not be wisely invested... therefore the only fat burning role that AOD will have legally is under the GRAS status in food... AND we probably can leave the discussion on AOD and fat there.

AOD for healing... now there is another matter and potential gold. Astounding volume of media on AOD and its healing properties in sport/athletes etc AND very recent and therefore extended life patents (muscle repair and joint cartilage repair)... hence a well designed phase II trial(perhaps $50-100K investment) will add information on the value of pursuing this further. I really hope that Polynovo provides turnover in the coming months to support the funds of a phase II trial of AOD in this area then Polynovo and Metabolic can be separated with positive news in both companies and value created for shareholders of each...

On a different topic...

Bring on BARDA success, a positive second clinical trial, 510k approval of the TNP dressing and a commercial deal... in that order and all before Christmas please!

Gav